Hepatocellular carcinoma: Correlation between gadobenate dimeglumine- enhanced MRI and pathologic findings

Investigative Radiology

Volumn 35, Issue 1, 2000, Pages 25-34

  Grazioli, Luigi ^a,d   Morana, Giovanni ^b   Caudana, Roberto ^b   Benetti, Anna ^a   Portolani, Nazario ^a   Talamini, Giorgio ^b   Colombari, Romano ^b   Pirovano, Gianpaolo ^c   Kirchin, Miles A ^c   Spinazzi, Alberto ^c  

^a UNIVERSITY OF BRESCIA   (Italy)

^b UNIVERSITY OF VERONA   (Italy)

^c Bracco SpA   (Italy)

^d SPEDALI CIVILI   (Italy)

Author keywords

Gadobenate dimeglumine; Gd BOPTA; Hepatocellular carcinoma; MR imaging

Indexed keywords

GADOBENATE DIMEGLUMINE; GADOBENIC ACID;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTRAST ENHANCEMENT; DOSE RESPONSE; DRUG MECHANISM; FEMALE; HUMAN; HUMAN TISSUE; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; LIVER FAILURE; LIVER NECROSIS; LIVER PARENCHYMA; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; SIGNAL NOISE RATIO; TUMOR VASCULARIZATION;

EID: 12944255849     PISSN: 00209996     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004424-200001000-00003     Document Type: Article

References (30)

1. Haase A, Framm J, Matthaei D, et al. Flash imaging: Rapid NMR imaging using low flip angle pulses. J Magn Reson Imaging 1986; 67:217-225.
2. Mills TC, Ortendahl DA, Hylton NM, et al. Partial flip angle MR imaging. Radiology 1987;162:531-539.
3. Semelka RC, Simm FC, Recht M, et al. T1-weighted sequences for MR imaging of the liver: Comparison of three techniques for single-breath whole-volume acquisition at 1.0 and 1.5 T. Radiology 1991;180:629-625.
4. Urhahn R, Drobnitzky M, Hlose KJ, Gunther RW. Incremental flip angle snapshot FLASH MRI of hepatic lesions: Improvement of signal-to-noise and contrast. J Comput Assist Tomogr 1992;16:219-225.
5. Low RN, Francis IR, Herfkens RJ. Fast multiplanar spoiled gradient-recalled imaging of the liver: Pulse sequence optimization and comparison with spin-echo MR imaging. AJR 1993;160:501-509.
6. Rydberg JN, Lomas DJ, Coakley KJ, et al. Comparison of breath-hold fast spin-echo and conventional spin-echo pulse sequences for T2-weighted MR imaging of liver lesions. Radiology 1995;194:431-437.
7. Rummeny E, Ehrenheim C, Gehl HB, et al. Manganese-DPDP as a hepatobiliary contrast agent in the magnetic resonance imaging of liver tumors: Results of clinical phase II trials in Germany including 141 patients. Invest Radiol 1991;26:S142-S145.
8. Reimer P, Rummeny EJ, Daldrup HE, et al. Clinical results with Resovist: A phase II clinical trial. Radiology 1995;195:489-496.
9. Reimer P, Rummeny EJ, Shamsi K, et al. Phase II clinical evaluation of Gd-EOB-DTPA: Dose, safety aspects and pulse sequence. Radiology 1996;199:177-183.
10. Caudana R, Morana G, Pirovano G, et al. Focal malignant hepatic lesions: MR imaging enhanced with gadolinium benzyloxypropionictetra-acetate (BOPTA) - Preliminary results of phase II clinical application. Radiology 1997;203:51-3-520.
11. Kirchin MA, Pirovano G, Spinazzi A. Gadobenate dimeglumine (Gd-BOPTA): An overview. Invest Radiol 1998;33:798-809.
12. Spinazzi A, Lorusso V, Pirovano GP, Kirchin M. Safety, tolerability, biodistribution and MR enhancement of the liver with Gd-BOPTA: Results of clinical pharmacology and pilot imaging studies in non-patient and patient volunteers. Acad Radiol 1999;6:282-291.
13. de Haën C, La Ferla R, Maggioni F. Gadobenate dimeglumine 0.5M solution for injection (MultiHance) as contrast agent for magnetic resonance imaging of the liven Mechanistic studies in animals. J Comput Assist Tomogr, 199;23(Suppl 23):S169-S179.
14. Vogl TJ, Pegios W, McMahon C, et al. MultiHance: A new contrast agent for MR imaging-preliminary evaluation in healthy volunteers. AJR 1992;157:887-892.
15. Spinazzi A, Lorusso V, Pirovano G, et al. MultiHance clinical pharmacology: Biodistribution and MR enhancement of the liver. Acad Radiol 1998;5:S86-S89.
16. Hamm B, Kirchin MA, Pirovano G. Clinical utility and safety of MultiHance in MRI of liver cancer: Results of multicenter studies in Europe and the USA. J Comput Assist Tomogr; 1999;23(Suppl 1):S53-S60.
17. Hamm B, Bassi AM, Grazioli L, et al. MultiHance-enhanced dynamic and delayed MR imaging in the detection and characterization of focal liver lesions [abstract]. In: Proceedings of the International Society for Magnetic Resonance in Medicine. Vancouver, 1997:67.
18. Vogl TJ, Stupavsky A, Pegios W, et al. Hepatocellular carcinoma: Evaluation with dynamic and static gadobenate dimeglumine-enhanced MR imaging and histopathologic correlation. Radiology 1997;205:721-728.
19. Manfredi R, Maresca G, Baron RL, et al. Delayed MR imaging of hepatocellular carcinoma enhanced by gadobenate dimeglumine (Gd-BOPTA). J Magn Reson Imaging 1999;9:704-710.
20. Child CG, Turcotte JG. Surgery and portal hypertension. In: Child CG, ed. The liver and portal hypertension. Philadelphia: WB Saunders, 1964:1-85.
21. Edmonson HA, Steiner PE. Primary carcinoma of the liver: A study of 100 cases among 48,900 necropsies. Cancer 1954;7:462-503.
22. Davenport WD, Ball CR. Observations on the results of specific histochemical techniques and empirical staining methods on several tissue/organ types using a variety of fixing fluids. Histopathology 1979;3:321-327.
23. Ebara M, Ohto M, Watanabe Y, et al. Diagnosis of small hepatocellular carcinoma: Correlation of MR imaging and tumor histologic studies. Radiology 1986;159:371-377.
24. Kadoya M, Matsui O, Takashima T, Nonomura A. Hepatocellular carcinoma: Correlation of MR imaging and histopathologic findings. Radiology 1992;183:819-825.
25. Bartolozzi C, Lencioni R, Caramella D, et al. Correlazioni tra risonanza magnetica e istologia nel carcinoma epatocellulare. Radiol Med 1994;87:90-95.
26. Yamashita Y, Fan ZM, Yamamoto H, et al. Spin echo and dynamic gadolinium-enhanced FLASH MR imaging of hepatocellular carcinoma: Correlation with histopathologic findings. J Magn Reson Imaging 1994;4:83-90.
27. Winter TC, Takayasu K, Muramatsu Y, et al. Early advanced hepatocellular carcinoma: Evaluation of CT and MR appearance with pathologic correlation. Radiology 1994;192:379-387.
28. Earls JP, Theise ND, Weinreb JC, et al. Dysplastic nodules and hepatocellular carcinoma: Thin-section MR imaging of explanted cirrhotic livers with pathologic correlation. Radiology 1996;201:207-214.
29. Manfredi R, Maresca G, Baron RL, et al. Gadobenate dimeglumine (Gd-BOPTA) enhanced MR imaging: Patterns of enhancement in normal liver and cirrhosis. J Magn Reson Imaging 1998;8:862-867.
30. Murakami T, Baron RL, Peterson MS, et al. Hepatocellular carcinoma: Mangafodipir trisodium (Mn-DPDP) enhanced MR imaging. Radiology 1996;200:69-77.